Moshe Yaniv

Q: What Schools Are Affiliated With Moshe Yaniv

Moshe Yaniv is affiliated with the following schools: Weizmann Institute of Science, CINVESTAV, Hannover Medical School, Lund University, University of Cambridge

Moshe Yaniv's AcademicInfluence.com Rankings

Moshe Yaniv

Chemistry

#2176

World Rank

#3045

Historical Rank

chemistry Degrees

Moshe Yaniv

Biology

#6182

World Rank

#8842

Historical Rank

Molecular Biology

#619

World Rank

#634

Historical Rank

Neuroscience

#737

World Rank

#769

Historical Rank

Biochemistry

#768

World Rank

#872

Historical Rank

biology Degrees

Download Badge

Chemistry
Biology

Moshe Yaniv's Degrees

PhD Molecular Biology Weizmann Institute of Science

Why Is Moshe Yaniv Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Moshe Yaniv's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death (1995) (849)
Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex. (1996) (845)
Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma (1984) (662)
A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. (1993) (615)
Hepatocyte Nuclear Factor 1 Inactivation Results in Hepatic Dysfunction, Phenylketonuria, and Renal Fanconi Syndrome (1996) (615)
CARD4/Nod1 mediates NF‐κB and JNK activation by invasive Shigella flexneri (2001) (572)
JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress (2004) (558)
Defective planar cell polarity in polycystic kidney disease (2006) (533)
Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts (1988) (495)
The human SWI/SNF subunit Brm is a regulator of alternative splicing (2006) (473)
Altered control of cellular proliferation in the absence of mammalian brahma (SNF2α) (1998) (464)
Wild-type p53 can down-modulate the activity of various promoters. (1991) (438)
Characterization of junD: a new member of the jun proto‐oncogene family. (1989) (420)
Induction of apoptosis by the transcription factor c‐Jun (1997) (411)
E. coli DNA binding protein HU forms nucleosome-like structure with circular double-stranded DNA (1979) (408)
The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression (2000) (400)
Cell cycle‐dependent variations in c‐Jun and JunB phosphorylation: a role in the control of cyclin D1 expression (2000) (386)
Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. (1998) (339)
Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. (2002) (337)
Coordinated methyl and RNA binding is required for heterochromatin localization of mammalian HP1α (2002) (336)
The mammalian Jun proteins: redundancy and specificity (2001) (333)
RB and hbrm cooperate to repress the activation functions of E2F1. (1997) (329)
Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras (1994) (324)
A transcriptional network in polycystic kidney disease (2004) (313)
CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. (2001) (312)
The BPV1‐E2 trans‐acting protein can be either an activator or a repressor of the HPV18 regulatory region. (1987) (289)
Factors involved in control of tissue-specific expression of albumin gene (1987) (278)
Absence of nucleosomes in a fraction of SV40 chromatin between the origin of replication and the region coding for the late leader RNA (1980) (275)
JunD protects cells from p53-dependent senescence and apoptosis. (2000) (250)
Essential role for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentiation. (1999) (243)
vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. (1991) (243)
Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis (1997) (239)
Components of the Human SWI/SNF Complex Are Enriched in Active Chromatin and Are Associated with the Nuclear Matrix (1997) (236)
Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. (2001) (234)
The hbrm and BRG‐1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. (1996) (233)
Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. (1982) (229)
Transformation by ras modifies AP1 composition and activity (1997) (226)
A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. (1988) (225)
The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes (1989) (224)
HNF1, a homeoprotein member of the hepatic transcription regulatory network (1992) (218)
Structural and mutational analysis of E2 trans‐activating proteins of papillomaviruses reveals three distinct functional domains. (1988) (212)
When the SWI/SNF complex remodels … the cell cycle (2001) (211)
Expression of the vHNF1/HNF1β homeoprotein gene during mouse organogenesis (1999) (210)
ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. (1999) (196)
Analysis of the distribution of binding sites for a tissue-specific transcription factor in the vertebrate genome. (1997) (195)
HNF1α controls renal glucose reabsorption in mouse and man (2000) (191)
Promoter Specificity and Biological Activity of Tethered AP-1 Dimers (2002) (186)
SWI/SNF chromatin remodeling and cancer. (2002) (176)
Defective Pancreatic β-Cell Glycolytic Signaling in Hepatocyte Nuclear Factor-1α-deficient Mice* (1998) (160)
Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. (1988) (158)
Tethering of HP1 proteins to chromatin is relieved by phosphoacetylation of histone H3 (2004) (158)
Degradation of transcription factors, c‐Jun and c‐Fos, by calpain (1991) (158)
Hepatic nuclear factor 1 (HNF1) shows a wider distribution than products of its known target genes in developing mouse. (1991) (156)
Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes (1992) (155)
Characterization of mammary tumors from Brg1 heterozygous mice (2008) (154)
The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. (1991) (153)
Several distinct "CCAAT" box binding proteins coexist in eukaryotic cells. (1988) (151)
Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts (1997) (150)
Assembly of transfected DNA into chromatin: structural changes in the origin‐promoter‐enhancer region upon replication. (1984) (149)
A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. (1995) (143)
Targeted disruption of the murine junD gene results in multiple defects in male reproductive function. (2000) (142)
Two different factors bind to the alpha‐domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c‐fos enhancers. (1987) (142)
Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes (1997) (139)
Chromatin-Like Structures in Polyoma Virus and Simian Virus 40 Lytic Cycle (1976) (136)
Tissue‐specific expression is conferred by a sequence from the 5′ end of the rat albumin gene. (1984) (133)
Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system (1987) (132)
Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter (2003) (130)
More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing. (1993) (130)
Overexpression of c-jun, junB, or junD affects cell growth differently. (1991) (129)
Transcription factor‐dependent regulation of CBP and P/CAF histone acetyltransferase activity (2001) (128)
Nucleotide Sequence of E. coli B tRNAVal1 (1969) (128)
A single mutational modification of a tryptophan-specific transfer RNA permits aminoacylation by glutamine and translation of the codon UAG. (1974) (127)
Deciphering AP-1 Function in Tumorigenesis: Fra-ternizing on Target Promoters (2007) (125)
SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. (2005) (123)
Photochemistry of 4-thiouridine in Escherichia coli transfer RNA1Val. (1971) (121)
Unregulated expression of c‐Jun or c‐Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells. (1991) (120)
The photochemistry of 4-thiouridine in Escherichia coli t-RNA Vał1. (1969) (118)
A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. (1990) (117)
Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region (1980) (117)
Hepatocyte dedifferentiation and extinction is accompanied by a block in the synthesis of mRNA coding for the transcription factor HNF1/LFB1. (1990) (117)
The mammalian SWI/SNF complex and the control of cell growth. (1999) (112)
ras transformation is associated with decreased expression of the brm/SNF2α ATPase from the mammalian SWI–SNF complex (1998) (111)
Temporally controlled targeted somatic mutagenesis in embryonic surface ectoderm and fetal epidermal keratinocytes unveils two distinct developmental functions of BRG1 in limb morphogenesis and skin barrier formation (2005) (111)
Fluorescence studies of interactions between Escherichia coli valyl-tRNA synthetase and its substrates. (1971) (110)
Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells (1987) (109)
Genomic structure of the cottontail rabbit (Shope) papillomavirus. (1985) (108)
Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. (2009) (107)
Liver Gene Expression (1994) (107)
vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression (1991) (106)
Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells (1981) (106)
Two members of an HNF1 homeoprotein family are expressed in human liver (1991) (105)
Increased DNA Damage Sensitivity and Apoptosis in Cells Lacking the Snf5/Ini1 Subunit of the SWI/SNF Chromatin Remodeling Complex (2006) (104)
Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes (1983) (103)
Papillomavirus E2 induces p53-independent apoptosis in HeLa cells (1999) (103)
Nuclear Covalently Closed Circular Viral Genomic DNA in the Liver of Hepatocyte Nuclear Factor 1α-Null Hepatitis B Virus Transgenic Mice (2001) (102)
Structure of Transfer RNA: Evidence for Interaction between Two Non-adjacent Nucleotide Residues in tRNAVal1 from Escherichia coli (1969) (99)
Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. (2002) (97)
Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens (1987) (96)
The SWI/SNF chromatin‐remodeling complex subunit SNF5 is essential for hepatocyte differentiation (2005) (93)
Stress‐activated protein kinases are negatively regulated by cell density (1998) (93)
Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18 (1988) (93)
The papillomavirus E2 protein: a factor with many talents. (1991) (93)
Anatomy of a Homeoprotein Revealed by the Analysis of Human MODY3 Mutations* (1999) (92)
The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter (1994) (90)
A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network. (2005) (88)
A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant‐transmitted fulminant hepatitis B (1997) (88)
Hepatocyte nuclear factor 1alpha gene inactivation impairs chromatin remodeling and demethylation of the phenylalanine hydroxylase gene (1997) (84)
HNF1alpha controls renal glucose reabsorption in mouse and man. (2000) (83)
Human papillomavirus DNA: physical map. (1975) (82)
The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. (1995) (82)
Constitutive synthesis of activator protein 1 transcription factor after viral transformation of mouse fibroblasts. (1988) (81)
The Activity of Mammalian brm/SNF2α Is Dependent on a High-Mobility-Group Protein I/Y-Like DNA Binding Domain (1999) (80)
SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity. (2009) (79)
Fine structure of the origin-proximal DNAase I-hypersensitive region in wild-type and EC mutant polyoma (1981) (79)
Growth inhibition by the mammalian SWI–SNF subunit Brm is regulated by acetylation (2003) (79)
The rat albumin promoter: cooperation with upstream elements is required when binding of APF/HNF1 to the proximal element is partially impaired by mutation or bacterial methylation (1989) (79)
Bidirectional Transcription and the Regulation of Phage λ Repressor Synthesis (1972) (79)
Both Jun and Fos contribute to transcription activation by the heterodimer. (1990) (77)
Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression (2002) (77)
Protein-binding elements in the promoter region of the mouse p53 gene. (1990) (77)
Roles of Brahma and Brahma/SWI2-Related Gene 1 in Hypoxic Induction of the Erythropoietin Gene* (2004) (76)
Specific interaction of cellular factors with the B enhancer of polyoma virus. (1985) (76)
The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. (2008) (75)
A dimer of BPV‐1 E2 containing a protease resistant core interacts with its DNA target. (1988) (75)
Impaired intervertebral disc formation in the absence of Jun (2003) (75)
Lack of JunD Promotes Pressure Overload–Induced Apoptosis, Hypertrophic Growth, and Angiogenesis in the Heart (2005) (73)
Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1alpha-deficient mice. (1998) (69)
Studies on the expression of an H‐2K/human growth hormone fusion gene in giant transgenic mice. (1986) (68)
The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1. (1993) (68)
Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. (1994) (66)
Functional interference between the Spi‐1/PU.1 oncoprotein and steroid hormone or vitamin receptors. (1993) (65)
Chromatin remodeling: from transcription to cancer. (2014) (65)
JunD protects against chronic kidney disease by regulating paracrine mitogens. (2003) (64)
Nucleotide sequence of the thrA gene of Escherichia coli. (1980) (64)
Control of HPV 18 DNA replication by cellular and viral transcription factors. (1995) (64)
A direct interaction between JNK1 and CrkII is critical for Rac1‐induced JNK activation (2001) (64)
Cloning of human hepatic nuclear factor 1 (HNF1) and chromosomal localization of its gene in man and mouse. (1990) (64)
Selective Deletion of the Hnf1β (MODY5) Gene in β-Cells Leads to Altered Gene Expression and Defective Insulin Release (2004) (63)
Nicking-closing enzyme assembles nucleosome-like structures in vitro. (1979) (63)
The transcription factor JunD mediates transforming growth factor β-induced fibroblast activation and fibrosis in systemic sclerosis (2011) (63)
Molecular cloning, refined physical map and heterogeneity of methylation sites of papilloma virus type 1a DNA. (1980) (62)
The rat albumin promoter is composed of six distinct positive elements within 130 nucleotides (1989) (61)
Papillomavirus genomes: sequences and consequences. (1984) (61)
Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance (1990) (61)
Hepatocyte nuclear factor 1 alpha controls renal expression of the Npt1-Npt4 anionic transporter locus. (2002) (60)
Structure of Transfer RNA: Molecular Model for Transfer RNA (1969) (59)
Control of papillomavirus gene expression. (1990) (59)
Fra‐1 promotes growth and survival in RAS‐transformed thyroid cells by controlling cyclin A transcription (2007) (58)
Sequence relationship of three valine acceptor tRNAs from Escherichia coli. (1971) (57)
Fine structure of the cottontail rabbit papillomavirus mRNAs expressed in the transplantable VX2 carcinoma (1985) (56)
An enhanceosome containing the Jun B/Fra‐2 heterodimer and the HMG‐I(Y) architectural protein controls HPV18 transcription (2000) (55)
Fine structure of the regulatory region of simian virus 40 minichromosomes revealed by DNAase I digestion. (1982) (55)
AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene (2005) (55)
Structure of transcriptionally active chromatin. (1986) (53)
The human brm protein is cleaved during apoptosis: The role of cathepsin G (2001) (53)
Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development. (2003) (52)
Oncogenes as Transcriptional Regulators (1997) (52)
A potent enhancer made of clustered liver-specific elements in the transcription control sequences of human alpha 1-microglobulin/bikunin gene. (1992) (52)
Functional analysis of the papilloma virus E2 trans-activator in Saccharomyces cerevisiae. (1989) (50)
Fluorescence study of interactions between valyl- t RNA synthetase and valine-specific tRNA's from Escherichia coli. (1969) (50)
Comparative small-angle x-ray scattering studies on unacylated, acylated and cross-linked Escherichia coli transfer RNA I Val . (1972) (49)
A yeast homolog of chromatin assembly factor 1 is involved in early ribosome assembly (2001) (49)
Studies on valyl-tRNA synthetase and tRNA from Escherichia coli. II. Interaction between valyl-tRNA synthetase and valine acceptor tRNA. (1969) (47)
Stimulation of protein kinase C or protein kinase A mediated signal transduction pathways shows three modes of response among serum inducible genes. (1989) (47)
Photosensitized splitting of thymine dimers in DNA by gene 32 protein from phage T 4. (1976) (46)
Rapid turnover of acetyl groups in the four core histones of simian virus 40 minichromosomes. (1979) (46)
Selective deletion of the Hnf1beta (MODY5) gene in beta-cells leads to altered gene expression and defective insulin release. (2004) (44)
Enhancing elements for activation of eukaryotic promoters (1982) (44)
Frequent Alterations of the β-Catenin Protein in Cancer of the Uterine Cervix (2002) (44)
Studies on valyl-tRNA synthetase and tRNAVal from Escherichia coli, (1969) (43)
Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype. (1990) (43)
The nucleotide sequences of the two glutamine transfer ribonucleic acids from Escherichia coli. (1975) (43)
Regulation of eukaryotic gene expression by transactivating proteins and cis acting DNA elements (1984) (42)
Biological activity of irradiated tRNA Val containing a 4-thiouridine-cytosine dimer. (1971) (42)
Preferential association of newly synthesized histones with replicating SV40 DNA (1977) (42)
DNA replication origin of polyoma virus: early proximal boundary (1983) (41)
Rebuilding the road to cancer (1999) (41)
The bovine papillomavirus type 1 (BPV1) replication protein E1 modulates transcriptional activation by interacting with BPV1 E2 (1994) (41)
Coding properties and nucleotide sequences of E. coli glutamine tRNAs. (1972) (40)
Random location and absence of movement of the nucleosomes on SV 40 nucleoprotein complex isolated from infected cells. (1976) (40)
JunD is a profibrogenic transcription factor regulated by Jun N‐terminal kinase‐independent phosphorylation (2006) (40)
The Bifunctional DCOH Protein Binds to HNF1 Independently of Its 4-α-Carbinolamine Cehydratase Activity (1997) (39)
Sequential assembly of newly synthesized histones on replicating SV40 DNA. (1980) (39)
Studies on valyl-tRNA synthetase and tRNA from Escherichia coli. I. Purification and properties of the enzyme from normal Escherichia coli strains. (1969) (39)
Chromatin modifiers and tumor suppression. (2001) (38)
HMG-I(Y) and the CBP/p300 Coactivator Are Essential for Human Papillomavirus Type 18 Enhanceosome Transcriptional Activity (2003) (37)
Several different upstream promoter elements can potentiate transactivation by the BPV‐1 E2 protein. (1991) (36)
Absence of nucleosomes in a histone-containing nucleoprotein complex obtained by dissociation of purified SV40 virions (1982) (35)
Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses (1988) (34)
Tropomyosin synthesis accompanies formation of actin filaments in embryonal carcinoma cells induced to differentiate by hexamethylene bisacetamide. (1979) (34)
Structural analysis of the human papillomavirus type 16-E2 transactivator with antipeptide antibodies reveals a high mobility region linking the transactivation and the DNA-binding domains. (1991) (34)
Nucleotide sequence of the thrB gene of E. coli, and its two adjacent regions; the thrAB and thrBC junctions. (1981) (33)
JunD Protects the Liver from Ischemia/Reperfusion Injury by Dampening AP-1 Transcriptional Activation* (2008) (32)
Anatomy of the rat albumin promoter. (1990) (32)
Mitochondrial Dysfunction Contributes to Impaired Insulin Secretion in INS-1 Cells with Dominant-negative Mutations of HNF-1α and in HNF-1α-deficient Islets* (2009) (31)
Actin and tubulin in teratocarcinoma cells. Amount and intracellular organization upon cytodifferentiation. (1978) (31)
Physical and biological features of polyoma virus mutants able to infect embryonal carcinoma cell lines (1982) (31)
Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation. (2007) (31)
Presence of one polypeptide chain in valyl and isoleucyl tRNA synthetases from Escherichia coli. (1970) (31)
Alpha/Beta Interferon Differentially Modulates the Clearance of Cytoplasmic Encapsidated Replication Intermediates and Nuclear Covalently Closed Circular Hepatitis B Virus (HBV) DNA from the Livers of Hepatocyte Nuclear Factor 1α-Null HBV Transgenic Mice (2005) (31)
Transcription of polyoma virus DNA in vitro. II. Transcription of superhelical and linear polyoma DNA by RNA polymerase II. (1978) (30)
Chromosomal localization of the three members of the jun proto-oncogene family in mouse and man. (1990) (30)
Studies on valyl-tRNA synthetase and tRNA from Escherichia coli. 3. Valyl-tRNA synthetases from thermosensitive mutants of Escherichia coli. (1969) (30)
Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence. (1989) (30)
Retinal photoreceptors are apoptosis-competent in the absence of JunD/AP-1. (1999) (29)
Transcription of polyoma virus DNA in vitro. Localization of Escherichia coli RNA polymerase initiation sites. (1976) (28)
Essential role for the homeoprotein vHNF 1 / HNF 1 β in visceral endoderm differentiation (27)
Transcription of polyoma virus DNA in vitro. III. Localization of calf thymus RNA polymerase II binding sites. (1978) (26)
Simian virus 40 illegitimate recombination occurs near short direct repeats. (1984) (25)
Structure and function of the promoter-enhancer region of polyoma and SV40. (1983) (25)
The transactivation potential of variant hepatocyte nuclear factor 1 is modified by alternative splicing. (1993) (25)
The human papillomavirus type 18 (HPV18) replication protein E1 is a transcriptional activator when interacting with HPV18 E2. (1998) (25)
Human papillomavirus DNA: physical mapping of the cleavage sites of Bacillus amyloliquefaciens (BamI) and Haemophilus parainfluenzae (HpaII) endonucleases and evidence for partial heterogeneity (1977) (24)
Molecular analysis of the interaction between an enhancer binding factor and its DNA target. (1986) (24)
Structure of the gene encoding hepatocyte nuclear factor 1 (HNF1). (1992) (24)
Nicking-closing enzyme is associated with SV40 DNA in vivo as a sodium dodecyl sulfate-resistant complex. (1979) (23)
Human Papillomavirus Type 8 E2 Protein Unravels JunB/Fra-1 as an Activator of the β4-Integrin Gene in Human Keratinocytes (2009) (23)
Transcription mechanisms and regulation: edited by RC Conaway, JW Conaway, Raven Press, 1994, $ 157.50, 570 p (1994) (23)
A high-resolution electron microscopy study of nucleosomes from simian virus 40 chromatin. (1981) (22)
Hepatocyte Nuclear Factor 1α Controls the Expression of Terminal Complement Genes (2001) (22)
Two DNA-bound E2 dimers are required for strong transcriptional activation and for cooperation with cellular factors in most cells. (1991) (21)
Assembly of SV40 and polyoma minichromosomes during replication. (1978) (21)
Control elements situated downstream of the major transcriptional start site are sufficient for highly efficient polyomavirus late transcription (1989) (21)
High resolution two‐dimensional electrophoresis of proteins bound to heterogeneous nuclear RNA (1977) (20)
NFY or a related CCAAT binding factor can be replaced by other transcriptional activators for co-operation with HNF1 in driving the rat albumin promoter in vivo. (1991) (20)
Both early and late control sequences of SV40 and polyoma promote transcription of Escherichia coli gpt gene in transfected cells. (1982) (19)
Identification of growth-factor-inducible genes in mouse fibroblasts. (1988) (19)
A set of polyclonal and monoclonal antibodies reveals major differences in post-translational modification of the rat HNF1 and vHNF1 homeoproteins. (1997) (19)
Bidirectional transcription and the regulation of Phage lambda repressor synthesis. (1972) (19)
Synergistic transcriptional-activation by the papillomavirus E2 protein occurs after DNA binding and correlates with a change in chromatin structure. (1997) (18)
Nucleotide sequences from messenger RNA transcribed from the operator-proximal portion of the tryptophan operon of Escherichia coli. (1973) (18)
The HNF1 C-terminal domain contributes to transcriptional activity and modulates nuclear localisation. (1993) (18)
Small DNA tumour viruses and their contributions to our understanding of transcription control. (2009) (18)
Abundant excretion of human growth hormone by recombinant-plasmid-transformed monkey kidney cells. (1983) (17)
Deletions of N-terminal sequences of polyoma virus T-antigens reduce but do not abolish transformation of rat fibroblasts (1982) (17)
E2 proteins: modulators of papillomavirus transcription and replication. (1996) (17)
Dimer composition and promoter context contribute to functional cooperation between AP-1 and NFAT. (2007) (17)
Escherichia coli RNA polymerase in vitro mimics simian virus 40 in vivo transcription when the template is viral nucleoprotein. (1980) (17)
Frequent alterations of the beta-catenin protein in cancer of the uterine cervix. (2002) (17)
Fos and Jun oncogenes transactivate chimeric or native promoters containing AP1/GCN4 binding sites in plant cells. (1990) (16)
Phosphorescence from sulfur-containing bases in Escherichia coli t-RNA. (1968) (16)
A single element mediates glucocorticoid hormone response of HPV18 with no functional interactions with AP1 or hbrm. (1996) (15)
The 50th anniversary of the publication of the operon theory in the Journal of Molecular Biology: past, present and future. (2011) (14)
Tethering of HP 1 proteins to chromatin is relieved by phosphoacetylation of histone H 3 (2004) (14)
c-jun regulation and function in the developing hindbrain. (2003) (14)
Temperature-jump relaxation studies on transfer ribonucleic acids. Valine and tyrosine-specific tRNAs from Escherichia coli. (1971) (13)
Embryonic but Not Postnatal Reexpression of Hepatocyte Nuclear Factor 1α (HNF1α) Can Reactivate the Silent Phenylalanine Hydroxylase Gene in HNF1α-Deficient Hepatocytes (2001) (13)
Proteins bound to heterogeneous nuclear RNA of simian-virus-40-infected cells. (1978) (12)
How do eukaryotic activator proteins stimulate the rate of transcription by RNA polymerase II? (1992) (12)
Introduction: Human papillomavirus (1996) (11)
SV40-alpha-globulin hybrid minichromosomes. Differences in DNase I hypersensitivity of promoter and enhancer sequences. (1984) (11)
Localization of the binding sites of prokaryotic and eukaryotic RNA polymerases on simian virus 40 DNA. (2005) (10)
gal4 transcription activator protein of yeast can function as a repressor in Escherichia coli. (1987) (10)
Location of the T4 gene 32 protein-binding site on polyoma virus DNA. (1974) (10)
Denaturation map of polyoma DNA (1975) (10)
Location of the T4 gene 32 protein binding site on polyoma virus DNA (1975) (9)
Signal Transduction Pathways and Modulation of Gene Activity (1998) (9)
Molecular model for transfer RNA. (1969) (8)
Expression in mammalian cells of the diaminopimelic acid decarboxylase of Escherichia coli permits cell growth in lysine-free medium. (1985) (8)
Role of chromatin structure, histone acetylation, and the primary sequence of DNA in the expression of SV40 and polyoma in normal or teratocarcinoma cells. (1981) (8)
The bifunctional DCOH protein binds to HNF1 independently of its 4-alpha-carbinolamine dehydratase activity. (1997) (8)
Transcription of SV 40 nucleoprotein complexes in vitro. (1977) (8)
Construction and expression of a hybrid plasmid containing the Escherichia coli thrA and thrB genes (1979) (8)
In vitro transforming capacities of mouse c-jun:junD chimeric genes. (1993) (7)
Comparative studies of the expression of linked Escherichia coli gpt gene and BPV-1 DNAs in transfected cells. (1983) (7)
Nucleotide sequence of E. coli B tRNA1-Val. (1969) (7)
Production of spliced DNA copies of the cottontail rabbit papillomavirus genome in a retroviral vector. (1986) (7)
Embryonic but not postnatal reexpression of hepatocyte nuclear factor 1alpha (HNF1alpha) can reactivate the silent phenylalanine hydroxylase gene in HNF1alpha-deficient hepatocytes. (2001) (7)
Transfected mouse c-jun can inhibit transformation of primary rat embryo fibroblasts. (1991) (6)
Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative. (1993) (6)
Identification of sulfur-containing bases in transfer ribonucleic acids by phosphorescence spectroscopy. (1970) (5)
SV 40 Nucleoprotein complexes: Structural modifications after isopycnic centrifugation in metrizamide gradients (1975) (5)
Comparative study of calf thymus and wheat germ RNA polymerase II: stability of initiation complexes and elongation rates. (1979) (5)
Use of retroviral vectors for mapping of splice sites in cottontail rabbit papillomavirus. (1988) (5)
Coprecipitation of topoisomerase activity with simian virus 40 nucleoprotein complexes by divalent cations. (1980) (4)
Cell cycle regulators and chromosomal translocation (1997) (4)
[Functional interaction between estrogen receptor and proto-oncogene products c-Jun and c-Fos]. (1991) (4)
Chromosomes and expression mechanisms: bringing together the roles of DNA, RNA and proteins. (2008) (4)
SWI/SNF chromatin remodeler complex within the reward pathway is required for behavioral adaptations to stress (2021) (3)
Assignment of HBRM, the human homolog of S. cerevisiae SNF2/SWI2 and Drosophila brm genes, to chromosome region 9p23–p24, by in situ hybridization (1994) (2)
INTRODUCTION OF AN INTRAMOLECULAR FLUORESCENT PROBE IN E. COLZ tRNA:d (1971) (2)
TheRatAlbumin Promoter: Cooperation withUpstream Elements Is Required whenBinding ofAPF/HNF1totheProximal Element Is Partially Impaired byMutation orBacterial Methylation (1989) (2)
Enhancer-mediated activation of a growth-regulated promoter. (1987) (2)
Construction of hybrid viruses in vitro and their possible use for the production of specific viral or cellular proteins. (1979) (2)
Oncogenes as Transcriptional Regulators (1997) (2)
Two RAREs and an overlapping CRE are involved in the hepatic transcriptional regulation of the Q10 MHC class I gene. (1996) (2)
Hepatocyte Nuclear Factor 1 (cid:2) Controls the Expression of Terminal Complement Genes (2001) (1)
The Polyoma Enhancer (1987) (1)
[On the properties of valyl-sRNA synthetase in various thermosensitive Escherichia coli mutants]. (1965) (1)
[Thermosensitive mutations of systems activating valine in E. coli]. (1965) (1)
With François Jacob, from temperature sensitive mutants of Escherichia coli to mouse development and diseases. (2014) (1)
[Oxidative stress and angiogenesis: major role of AP-1]. (2005) (1)
Nucleic Acids Research (0)
[he modified properties of valyl-t-RNA synthetases in Escherichia coli mutants with thermosensitive growth]. (1968) (0)
[Chromatin structure with no nucleosomes: dissociated SV40 virus]. (1981) (0)
[Expression of ts-3 mutant of polyoma virus in mouse cells (author's transl)]. (1979) (0)
Structure and Regulation of the c-jun Promoter (2017) (0)
Partnering and functioning of the MEN1 tumour suppressor gene (2004) (0)
Comparative Analysis oftheHumanTypelaandBovine Type 1Papillomavirus Genomes (1983) (0)
REGULATION DIFFERENTIELLE DES PROTO-ONCOGENES JUN PAR LES VOIES DEPENDANTES DU DIACYLGLYCEROL ET DE L'AMPc (1989) (0)
Effects of cytosol on transcription in isolated simian-virus-40-infected nuclei. (1979) (0)
[On the properties of a modified alanyl-t-RNA synthetase in a strain of escherichia coli with thermosensible growth]. (1968) (0)
Embryonic development , epigenics and somatic cell nuclear transfer-The science and its social implications - (2006) (0)
Table of Contents (1982) (0)
Transcription Control in Eucaryotes-Enhancers and Promoters (1985) (0)
TheHumanPapillomavirus Type18(HPV18)E2GeneProductIsa Repressor oftheHPV18Regulatory RegioninHuman Keratinocytes (1989) (0)
Table of Contents (1984) (0)
Letter to the Editor (1999) (0)
DNA fragments encoding polypeptides containing at least one antigenic determinant of papillomavirus, particularly of the type HPV 1a and corresponding polypeptides (1982) (0)
TwoAPISites Binding JunBAreEssential forHuman Papillomavirus Type18Transcription inKeratinocytes (1992) (0)
The Control of Human Papillomavirus Transcription (2018) (0)
Minireview How do eukaryotie activator proteins stimulate the rate of transcription by RNA polymerase II (1992) (0)
S.17.01 Regulation of transcription factors by signal transduction pathways (1997) (0)
TheE2Transcriptional Repressor CanCompensate forSP1Activation oftheHumanPapillomavirus Type18EarlyPromoter (1994) (0)
Dna fragment for papillomavirus (1996) (0)
Protein Constituents of Nuclear Ribonucleoprotein from Normal and Virus-SV40-Infected Cells (1977) (0)
Renal dysfunction in HNF 1 α / MODY 3 deficiency scientific reports (2013) (0)
Structure and Replication of SV40 Chromatin (1983) (0)
StudyoftheE2GeneProduct oftheCottontail Rabbit Papillomavirus Reveals a CommonMechanism ofTransactivation among Papillomaviruses (1988) (0)
The Mouse Jun Family (1989) (0)
Hepatocytes-Deficient α Hydroxylase Gene in HNF 1 Can Reactivate the Silent Phenylalanine ) α ( HNF 1 α of Hepatocyte Nuclear Factor 1 Embryonic but Not Postnatal Reexpression (2001) (0)
type 18. long control region of human papillomavirus Interplay of viral and cellular proteins along the (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Moshe Yaniv?

Moshe Yaniv is affiliated with the following schools:

Moshe Yaniv's Academic­Influence.com Rankings

Moshe Yaniv's Degrees

Why Is Moshe Yaniv Influential?

Moshe Yaniv's Published Works

Published Works

What Schools Are Affiliated With Moshe Yaniv?

Moshe Yaniv's AcademicInfluence.com Rankings